latest news stock values companies glp-1 obesity cardiometabolic Analogues Market Size to Hit USD 1,062.90 Billion by 2035 Obesity GLP-1 Market

Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, et al

Kybella is an injectable that can be a treatment for some of these concerns

Gudbergsen H, Henriksen M, Waehrens EE, Overgaard A, Bliddal H, Christensen R, Boesen MP, Knop FKK, Astrup A, Rasmussen MU, Bartholdy C, Daugaard C, Bartels EM, Ellegaard K, Heitmann BL, Kristensen LE (2019) Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial

While the meds and surgery are both effective weight loss tools, researchers are still exploring the long-term effects of GLP-1 receptor agonists (GLP-1 RAs) and how best to support muscle health alongside weight loss